Characterisation of Prognosis and Invasion of Cutaneous Squamous Cell Carcinoma by Podoplanin and E-Cadherin Expression
暂无分享,去创建一个
J. Klode | R. Gutzmer | U. Hillen | V. Schacht | I. Satzger | K. Schaper | B. Köther | K. Hesse | Brigitta Köther | Katrin Schaper
[1] I. Zalaudek,et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. , 2015, European journal of cancer.
[2] M. Beyer,et al. Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma , 2015, The British journal of dermatology.
[3] A. Khachemoune,et al. Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends , 2015, International journal of dermatology.
[4] P. Golusiński,et al. Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma , 2014, European Archives of Oto-Rhino-Laryngology.
[5] Juan Li,et al. Podoplanin: a novel regulator of tumor invasion and metastasis , 2014, Medical Oncology.
[6] Jia-qi Chen,et al. Immunolocalization of Vimentin, Keratin 17, Ki-67, Involucrin, β-Catenin and E-Cadherin in Cutaneous Squamous Cell Carcinoma , 2014, Pathology & Oncology Research.
[7] A. G. de Herreros,et al. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases. , 2013, Journal of dermatological science.
[8] J. Carucci,et al. Skin Cancer in Immunosuppressed Patients , 2013, Facial Plastic Surgery.
[9] A. Hauschild,et al. Brief S2k guidelines – Cutaneous squamous cell carcinoma , 2013, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[10] Jiali Han,et al. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. , 2013, Journal of the American Academy of Dermatology.
[11] A. Qureshi,et al. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. , 2013, JAMA dermatology.
[12] C. Mauch,et al. Podoplanin expression in cutaneous head and neck squamous cell carcinoma—prognostic value and clinicopathologic implications , 2013, Journal of surgical oncology.
[13] S. Mojal,et al. D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: a marker of metastatic risk. , 2012, Journal of the American Academy of Dermatology.
[14] C. Farah,et al. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation. , 2012, Oral oncology.
[15] P. Friedl,et al. Classifying collective cancer cell invasion , 2012, Nature Cell Biology.
[16] H. Breuninger,et al. Comparison and evaluation of the current staging of cutaneous carcinomas , 2012, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[17] J. Leonardi-Bee,et al. A systematic review of worldwide incidence of nonmelanoma skin cancer , 2012, The British journal of dermatology.
[18] A. Carvalho,et al. Prognostic and Risk Factors in Patients with Locally Advanced Cutaneous Squamous Cell Carcinoma of the Trunk and Extremities , 2011, Journal of skin cancer.
[19] C. Schmults,et al. Management of high-risk cutaneous squamous cell carcinoma. , 2010, The Journal of clinical and aesthetic dermatology.
[20] M. Schmelz,et al. Prognostic criteria for squamous cell cancer of the skin. , 2010, The Journal of surgical research.
[21] D. Cassarino,et al. Immunohistochemical Expression of D2-40 in Benign and Malignant Sebaceous Tumors and Comparison to Basal and Squamous Cell Carcinomas , 2008, The American Journal of dermatopathology.
[22] Suzanne M Olbricht,et al. Cutaneous squamous cell carcinoma. , 2008, Advances in dermatology.
[23] B. Schönfisch,et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. , 2008, The Lancet. Oncology.
[24] M. O’Banion,et al. Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism. , 2007, Cancer research.
[25] A. Weinberg,et al. Metastatic Cutaneous Squamous Cell Carcinoma: An Update , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[26] Jeffrey E. Lee,et al. Invasive Squamous Cell Carcinoma of the Skin: Defining a High-Risk Group , 2006, Annals of Surgical Oncology.
[27] G. Christofori,et al. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. , 2006, Cancer cell.
[28] Victor Prieto,et al. Lymph Node Metastases from Cutaneous Squamous Cell Carcinoma of the Head and Neck , 2005, The Laryngoscope.
[29] M. Detmar,et al. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. , 2005, The American journal of pathology.
[30] H. Trau,et al. Expression of E-Cadherin and Beta-Catenin in Cutaneous Squamous Cell Carcinoma and its Precursors , 2004, The American Journal of dermatopathology.
[31] Sate H Hamza,et al. Histologic Features in Primary Cutaneous Squamous Cell Carcinomas in Immunocompromised Patients Focusing on Organ Transplant Patients , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[32] A. Katalinic,et al. Epidemiology of cutaneous melanoma and non‐melanoma skin cancer in Schleswig‐Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer) , 2003, The British journal of dermatology.
[33] H. Beug,et al. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis , 2003, Nature Reviews Molecular Cell Biology.
[34] B. Smoller,et al. Reporting tumor thickness for cutaneous squamous cell carcinoma , 2002, Journal of cutaneous pathology.
[35] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[36] W. Dinjens,et al. E‐cadherin—catenin cell—cell adhesion complex and human cancer , 2000, The British journal of surgery.
[37] Y. Mitsuhashi,et al. An Immunohistochemical Study of E‐Cadherin Expression in Human Squamous Cell Carcinoma of the Skin , 1999, The Journal of dermatology.
[38] C. Cockerell,et al. Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis , 1997, Cancer.
[39] R. Carroll,et al. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. , 1992, Journal of the American Academy of Dermatology.
[40] N. Swanson,et al. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). , 1992, Journal of the American Academy of Dermatology.
[41] S. Frankel,et al. Non-melanoma Skin Cancer , 2021, Surgical Oncology Manual.
[42] S. Pollack,et al. Metastases from squamous cell carcinoma of the skin and lip , 1989 .